QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
LON:ADN

1724525 (ADN.L) (ADN) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
3.09 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ADN stock logo

About 1724525 (ADN.L) Stock (LON:ADN)

Aberdeen Asset Management PLC is a United Kingdom-based asset manager. The Company operates through asset management for reporting and control purposes. The Company is managed as a single asset management business, with multiple investment strategies of equities, fixed income and property, complemented by a solutions business, which provides multi asset, alternatives and quantitative investment capabilities. These strategies are managed across a range of products, distribution channels and geographic regions. The Company holds investments in seed capital investments, investments in certain Aberdeen-managed funds to hedge deferred fund awards and other investments. The Company operates in approximately 20 countries. Its operations span across Asia Pacific, Australia, the United Kingdom, the United States, the Middle East and Europe, among others.

ADN Stock News Headlines

Dr. Russell G. Hirano
Advent Technologies Holdings, Inc. (ADN)
See More Headlines
Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 1724525 (ADN.L) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Optical Instrument & Lens Manufacturing
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Martin James Gilbert LL.D.
    M.D., Chief Executive, Executive Director
  • Andrew A. Laing
    Deputy Chief Executive, Executive Director
  • Bever Hendry
    Co-Head of Americas and Chief Financial Officer
  • W. J. Rattray
    Finance Director, Executive Director
  • Martin Jennings
    Chief Executive Officer Parmenion and Head of Aberdeen Digital
  • Avril McLean
    Chief Technology Officer
  • Gordon H. Brough
    General Counsel
  • Hugh Young
    Managing Director of Aberdeen Asset Management Asia, Executive Director
  • Roderick MacLeod MacRae
    Group Head - Risk, Executive Director
  • Kerry Christie
    Global Head - Human Resources

ADN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of 1724525 (ADN.L) own?
How do I buy shares of 1724525 (ADN.L)?

Shares of ADN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ADN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners